Earnings live updates: Bank of America says consumer still solid, ASML stock drops

The article highlights a broadly positive Q1 earnings season, with analysts expecting the S&P 500 to post its sixth straight quarter of double-digit earnings growth. ASML raised 2026 revenue guidance to 36B-40B euros from 34B-39B euros on strong AI-chip demand, while Citigroup, JPMorgan, Johnson & Johnson, and BlackRock all reported beats or solid starts; Wells Fargo and Fastenal were weaker or in line, but overall earnings trends remain constructive.

Analysis

The key signal is not that earnings are merely beating; it is that the market is rewarding companies with durable pricing power and penalizing those exposed to late-cycle margin compression. That creates a sharp internal dispersion trade: AI infrastructure and asset-gathering franchises are converting capex and market volatility into visible forward revenue, while banks with weaker balance-sheet monetization and industrial distributors with flat demand are already being treated as “good enough” rather than premium quality.

ASML is the cleanest second-order winner here. The market is implicitly saying that the AI buildout is no longer just a story about chip demand, but about capacity lock-in: longer lead times and customer prepayments should support equipment utilization into 2026 even if end-demand slows. The risk is valuation compression, not fundamentals; that makes the stock more vulnerable to any modest guidance miss than to a macro slowdown, so the trade is strongest on pullbacks rather than chasing strength.

For financials, the divergence matters more than the headline beat. Citi’s trading-driven strength suggests dispersion and volatility are still monetizing well, while Wells Fargo’s miss is a reminder that spread income is still being squeezed by the timing of rate cuts. That argues for favoring markets/fee-driven balance sheets over plain vanilla lenders over the next 1-2 quarters, especially if the Fed delays easing or the curve stays flat.

The contrarian miss is that the broad S&P earnings narrative may be too dependent on a few AI, trading, and healthcare pockets. If the rest of the consumer and industrial complex is only treading water, the index can keep printing double-digit EPS growth while breadth deteriorates underneath; that usually ends with the market paying up for quality until one or two leadership names stumble, then rotating quickly into defensives and cash-generators.

Key Decisions for Investors

• Long ASML on a 3-6 month horizon, but prefer buying 5-8% pullbacks or using call spreads to avoid multiple compression risk; upside remains tied to 2026 capacity expansion, while downside is mainly valuation if guidance merely matches.
• Pair long BLK / short WFC for the next 1-2 quarters to express the view that fee-based asset gathering and market activity outperform rate-spread banking as the Fed stays later than expected on cuts.
• Use a short-dated hedge on NFLX or PEP into earnings if the book is already crowded long quality growth/defensive consumer; these are more likely to disappoint on forward commentary than on current-quarter optics.
• Tactically underweight FAST vs. better capitalized industrial names for the next quarter; flat growth plus margin pressure signals weaker end-demand and limited ability to reaccelerate near term.
• Maintain a small long bias in JNJ versus the broader healthcare basket, but only as a defensive ballast; the stock can work on relative safety, yet patent erosion means the fundamental inflection is months, not days.